Kythera Biopharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 77   

Articles published

KYTH 38.31 -0.11 (-0.29%)
price chart
Kythera Biopharmaceuticals Inc. (KYTH) Jumps 5.52% on November 25
Kythera Biopharmaceuticals Inc. (KYTH) was among the biggest gainers on the Russell 2000 for Tuesday November 25 as the stock popped 5.52% to $38.42, representing a gain of $2.01 per share.
Related articles »  
Why KYTHERA Biopharmaceuticals Inc. Shares Shot Higher
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Kythera Regains ATX-101 from Bayer  Zacks.com
KYTHERA Acquires Rights to ATX-101 Outside of the U.S. and Canada From ...  MarketWatch
Related articles »  
KYTHERA Biopharmaceuticals to Present at the Goldman Sachs US Emerging ...
WESTLAKE VILLAGE, Calif., Nov. 14, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that Keith Leonard, president and chief executive officer, will present at the Goldman Sachs US Emerging / SMID Cap ...
Related articles »  
KYTHERA Biopharmaceuticals Submits New Drug Submission to Health ...
WESTLAKE VILLAGE, Calif., Aug. 11, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced it submitted a New Drug Submission (NDS) to Health Canada seeking approval for the company's investigational drug, ...
Related articles »  
Kythera Biopharmaceuticals Inc. (KYTH) Jumps 5.77% on October 23
Kythera Biopharmaceuticals Inc. ($KYTH) was among the biggest gainers on the Russell 2000 for October 23 as the stock popped 5.77% to $36.11, representing a gain of $1.97 per share.
Related articles »  
KYTHERA Biopharmaceuticals Releases Third Quarter 2014 Operating Results
WESTLAKE VILLAGE, Calif., Nov. 10, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today reported financial results for its third quarter 2014 and provided an update on recent accomplishments.
Kythera Biopharmaceuticals Given New $59.00 Price Target at FBR Capital ...  WKRB News
Related articles »  
Company Update on High Short Interest:Kythera Biopharmaceuticals Inc ...
Kythera Biopharmaceuticals Inc (NASDAQ:KYTH) is currently valued at $36.41 per share. The shares are trading 35.4% off their 52-week peak and 19% above their 52-week low.
KYTHERA Biopharmaceuticals Grants Stock Options Under Inducement Program
KYTHERA Biopharmaceuticals, Inc. KYTH, +2.85% today announced that on October 31, 2014, the Compensation Committee of the Company's Board of Directors granted seven new employees options to purchase an aggregate of 46,000 shares of the ...
Kythera Biopharmaceuticals Director Sells $56189 in Stock (KYTH)  sleekmoney
Insider Selling: Kythera Biopharmaceuticals CEO Unloads 5865 Shares of Stock ...  Mideast Time
Related articles »  
KYTHERA Biopharmaceuticals Announces FDA Acceptance of ATX-101 New ...
CALABASAS, Calif., July 10, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that its New Drug Application (NDA) for ATX-101 (deoxycholic acid), has been accepted for filing by the U.S.
Kythera Reports FDA Acceptance of ATX-101 NDA, PDUFA Date Set at May 13 ...  Benzinga
Related articles »  
Yesterday's Top Gainers: Kythera Biopharmaceuticals, Inc. (KYTH ...
Kythera Biopharmaceuticals, Inc. (KYTH) of the Healthcare sector closed out the day yesterday with a change of 5.52%, a change from open of 6.070% and a volume of 366,745 shares.
Related articles »